AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
In a new data readout exploring a potential Tagrisso combination therapy, AstraZeneca revealed Monday morning that it’s all about the MET.
AstraZeneca reported that 32 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.